Hannu Norppa
New Technologies and Risks
Work Environment Development
Finnish Institute of Occupational Health
Topeliuksenkatu 41aA
Finland
Name/email consistency: high
- Conclusions and outlook. Norppa, H., Greim, H. Toxicol. Lett. (2009)
- Chromosomal aberrations and SCEs as biomarkers of cancer risk. Norppa, H., Bonassi, S., Hansteen, I.L., Hagmar, L., Strömberg, U., Rössner, P., Boffetta, P., Lindholm, C., Gundy, S., Lazutka, J., Cebulska-Wasilewska, A., Fabiánová, E., Srám, R.J., Knudsen, L.E., Barale, R., Fucic, A. Mutat. Res. (2006)
- Cytogenetic biomarkers. Norppa, H. IARC Sci. Publ. (2004)
- Cytogenetic biomarkers and genetic polymorphisms. Norppa, H. Toxicol. Lett. (2004)
- What do human micronuclei contain?. Norppa, H., Falck, G.C. Mutagenesis (2003)
- Genetic susceptibility, biomarker respones, and cancer. Norppa, H. Mutat. Res. (2003)